No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors

被引:37
|
作者
Rietbergen, Michelle M. [1 ]
Braakhuis, Boudewijn J. M. [1 ]
Moukhtari, Nadia [1 ]
Bloemena, Elisabeth [2 ,3 ]
Brink, Arjen [1 ]
Sie, Daoud [3 ]
Ylstra, Bauke [3 ]
de Jong, Robert J. Baatenburg [4 ]
Snijders, Peter J. F. [3 ]
Brakenhoff, Ruud H. [1 ]
Leemans, C. Rene [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands
[4] Erasmus MC, Dept Otolaryngol Head & Neck Surg, Rotterdam, Netherlands
关键词
SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY TUMORS; GENETICALLY ALTERED FIELDS; NECK-CANCER PATIENTS; CLINICAL-IMPLICATIONS; COPY NUMBER; ARRAY CGH; HEAD; CANCERIZATION; PREVALENCE;
D O I
10.1111/jop.12123
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with HPV-negative OPSCCs. Important factors contributing to this better prognosis are relatively low numbers of local/regional recurrences (LRRs) and second primary tumors (SPTs) in patients with HPV-positive OPSCC. These low numbers may be explained in addition by the absence of a 'field cancerization' effect, which is a cause of LRRs and SPTs in patients with HPV-negative OPSCC. We aimed to detect a possible 'field effect' in patients with HPV-positive OPSCC. As HPV is involved in the early stage of carcinogenesis in OPSCCs, its presence is considered a reliable marker for the detection of such a field effect. Therefore, the presence of transcriptionally active HPV was analyzed in the mucosa surrounding HPV-positive OPSCCs. Methods: We included 20 patients who were surgically treated for an HPV-positive OPSCC in the period 2000-2006. Of each patient, the formalin-fixed paraffin-embedded tumor sample and all available resection margins were collected. In total, 97 resection margins were investigated with an average of five resection margins per tumor. All samples were analyzed for the presence of tumor and the presence of transcriptionally active HPV by HPV16-E6-mRNA detection. Results: All tumors were HPV16-E6-mRNA positive. HPV16-E6-mRNA could be detected in the resection margins that contained tumor (n = 6). All tumor-negative resection margins (n = 91) scored negative for HPV16-E6-mRNA. Conclusions: In conclusion, transcriptional active HPV could not be detected in the mucosa surrounding an HPV-positive OPSCC, which suggests the absence of field effect. This observation may explain the lower number of LRRs and SPTs in HPV-positive patients. © 2013 John Wiley & Sons A/S.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [1] Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners
    D'Souza, Gypsyamber
    Gross, Neil D.
    Pai, Sara I.
    Haddad, Robert
    Anderson, Karen S.
    Rajan, Shirani
    Gerber, Jennifer
    Gillison, Maura L.
    Posner, Marshall R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) : 2408 - U191
  • [2] Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women
    Santos Filho, M. V. C.
    Gurgel, A. P. A. D.
    Lobo, C. D. P.
    Freitas, A. C. F.
    Silva-Neto, J. C.
    Silva, L. A. F.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02):
  • [3] Oral HPV infection in HPV-positive oropharyngeal cancer cases and their spouses
    D'Souza, Gypsyamber
    Gross, Neil D.
    Pai, Sara I.
    Haddad, Robert I.
    Gillison, Maura L.
    Posner, Marshall R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Surgery or radiotherapy for oropharyngeal HPV-positive tumours?
    Philouze, P.
    Ceruse, P.
    Thariat, J.
    CANCER RADIOTHERAPIE, 2018, 22 (6-7): : 481 - 486
  • [5] Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell Carcinoma
    Larish, Alyssa
    Yin, Linda
    Glaser, Gretchen
    Moore, Eric
    Bakkum-Gamez, Jamie
    Routman, David
    Ma, Daniel
    Price, Daniel
    Janus, Jeffrey
    Price, Katharine
    Chintakuntlawar, Ashish
    Neben-Wittich, Michelle
    Foote, Robert
    Van Abel, Kathryn
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2021, 164 (02) : 369 - 374
  • [6] Developing a Radiographic Model for Prediction of Clinical Outcomes in HPV-Positive Oropharyngeal Tumors
    Morris, L. K.
    Jeans, E.
    Harmsen, W. S.
    Garces, Y.
    Lester, S. C.
    Neben-Wittich, M. A.
    Patel, S. H.
    Foote, R. L.
    Ma, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E814 - E814
  • [7] Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors
    Klozar, Jan
    Koslabova, Eva
    Kratochvil, Vit
    Salakova, Martina
    Tachezy, Ruth
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (06) : 625 - 633
  • [8] Oral HPV infection in HPV-positive oropharyngeal cancer cases and their spouses.
    D'Souza, Gypsyamber
    Gross, Neil D.
    Pai, Sara I.
    Haddad, Robert I.
    Gillison, Maura L.
    Posner, Marshall R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
  • [9] Initial Symptoms in Patients With HPV-Positive and HPV-Negative Oropharyngeal Cancer
    McIlwain, Wesley R.
    Sood, Amit J.
    Nguyen, Shaun A.
    Day, Terry A.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 140 (05) : 441 - 447
  • [10] Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
    Wurlitzer, Marcus
    Moeckelmann, Nikolaus
    Kriegs, Malte
    Vens, Maren
    Omidi, Maryam
    Hoffer, Konstantin
    von Bargen, Clara
    Moeller-Koop, Christina
    Witt, Melanie
    Droste, Conrad
    Oetting, Agnes
    Petersen, Hannes
    Busch, Chia-Jung
    Muenscher, Adrian
    Schlueter, Hartmut
    Clauditz, Till Sebastian
    Rieckmann, Thorsten
    CANCERS, 2020, 12 (06) : 1 - 22